Thank you to the funding agencies that sponsor our research
ACTIVE FUNDING
Scope and safety of vaping during pregnancy - generating and disseminating knowledge to inform clinical practice and pregnant individuals
Canadian Institute of Health Research (CIHR)
Role: NPA (PA: Dr. K. Adamo, Dr. T. Nagpal)
2023-2024
Impact of opioid use during pregnancy on placental development and function
CIHR
Role: NPA (PA: Dr. L. Gaudet)
2021-2026
Fetal exposure to microplastics
Health Canada
Role: Co-Investigator (NPA: Dr. M. Wade)
2021-2023
Automated placenta screening to improve maternal lifetime cardiovascular health
CIHR-NSERC Collaborative Health Research Project
Role: NPA (PA: Dr. A. Chan, Dr. G. Smith)
2020-2024
DNA methylation profiling in cell-free DNA: a non-invasive method to screen for pre-term birth
CIHR
Role: Co-Investigator (PA: Dr. M. Hoffman)
2019-2024
PARP-dependent NAD+ depletion as a cause of placental dysfunction in preeclampsia
CIHR
Role: NPA (PA: Dr. K. Menzies)
2017-2024
CompleteD funding
The COVID-19 Ontario Pregnancy Event (COPE) Network: Assessing the impact of COVID-19 in pregnancy on maternal, fetal, and newborn health
CIHR
Role: Co-Investigator (NPA: Dr. D. El-Chaar)
2020-2021
Better understanding for better intervening: a collaborative approach to address opioid use in pregnancy for improved health and wellness
CIHR
Role: Co-Investigator (NPA: Dr. B. Fontaine-Bisson)
2018-2019
Improving Placental Function: Developing Screening Tools and Targeted Therapies for Preeclampsia
Ontario Ministry of Research and Innovation and Science - Early Researcher Award
Role: NPA
2017-2022
Does maternal physical activity affect placenta biology? A multi-tiered approach
CIHR
Role: Co-Investigator (NPA: Dr. K. Adamo)
2015-2020
Development of an antibody screening panel for the differential diagnosis of preeclampsia
Physicians Services Incorporated Foundation (PSI)
Role: PA (NPA: Dr. D. Grynspan)
2015-2019
DREAM: Determining Risk Elevation After Maternity
The Ottawa Hospital Academic Medical Organization
Role: Co-Investigator (NPA: Dr. L. Gaudet)
2015-2019
Role of FGL2 in placental development and preeclampsia
Preeclampsia Foundation Vision Award
Role: NPA
2015-2017
Identification of Molecular Subtypes of Preeclampsia
CIHR
Role: NAP (PA: Dr. B. Cox)
2013-2020
SIRT1: Identification of a novel placental stress-response protein that regulates fetal growth
Molly Towell Perinatal Research Foundation
Role: NPA
2013-2015
Placental Pathophysiology Research Laboratory
Canadian Foundation for Innovation (CFI)
Role: NPA
2011-2014